Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma.
Mol Ther Oncolytics. 2023 Aug 15;30:167-180. doi: 10.1016/j.omto.2023.08.005. eCollection 2023 Sep 21.
Mol Ther Oncolytics. 2023.
PMID: 37674626
Free PMC article.
Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma.
Abbott RC, Iliopoulos M, Watson KA, Arcucci V, Go M, Hughes-Parry HE, Smith P, Call MJ, Cross RS, Jenkins MR.
Abbott RC, et al.
Clin Transl Immunology. 2023 Mar 5;12(3):e1440. doi: 10.1002/cti2.1440. eCollection 2023.
Clin Transl Immunology. 2023.
PMID: 36890859
Free PMC article.
Item in Clipboard
To go or not to go? Biological logic gating engineered T cells.
Abbott RC, Hughes-Parry HE, Jenkins MR.
Abbott RC, et al.
J Immunother Cancer. 2022 Apr;10(4):e004185. doi: 10.1136/jitc-2021-004185.
J Immunother Cancer. 2022.
PMID: 35379738
Free PMC article.
Review.
Item in Clipboard
Erratum: Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma.
Abbott RC, Verdon DJ, Gracey FM, Hughes-Parry HE, Iliopoulos M, Watson KA, Mulazzani M, Luong K, D'Arcy C, Sullivan LC, Kiefel BR, Cross RS, Jenkins MR.
Abbott RC, et al.
Clin Transl Immunology. 2021 Jul 18;10(7):e1317. doi: 10.1002/cti2.1317. eCollection 2021.
Clin Transl Immunology. 2021.
PMID: 34295472
Free PMC article.
Item in Clipboard
Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma.
Abbott RC, Verdon DJ, Gracey FM, Hughes-Parry HE, Iliopoulos M, Watson KA, Mulazzani M, Luong K, D'Arcy C, Sullivan LC, Kiefel BR, Cross RS, Jenkins MR.
Abbott RC, et al.
Clin Transl Immunology. 2021 May 9;10(5):e1283. doi: 10.1002/cti2.1283. eCollection 2021.
Clin Transl Immunology. 2021.
PMID: 33976881
Free PMC article.
Item in Clipboard
Finding the Keys to the CAR: Identifying Novel Target Antigens for T Cell Redirection Immunotherapies.
Abbott RC, Cross RS, Jenkins MR.
Abbott RC, et al.
Int J Mol Sci. 2020 Jan 14;21(2):515. doi: 10.3390/ijms21020515.
Int J Mol Sci. 2020.
PMID: 31947597
Free PMC article.
Review.
Item in Clipboard
Cite
Cite